EXHIBIT 4.7
-----------
COMMON STOCK AND WARRANT PURCHASE AGREEMENT
DATED AS OF MAY 4, 2001
BY AND BETWEEN
XYBERNAUT CORPORATION
AND
ALPHA CAPITAL AKTIENGESELLSCHAFT
TABLE OF CONTENTS
PAGE
----
ARTICLE I PURCHASE AND SALE OF THE SHARES AND THE WARRANTS........................................................1
Section 1.1 Purchase and Sale of the Shares..............................................................1
Section 1.2 The Securities...............................................................................1
Section 1.3 Purchase Price and Closing...................................................................2
Section 1.4 Warrant......................................................................................2
ARTICLE II REPRESENTATIONS AND WARRANTIES.........................................................................2
Section 2.1 Representation and Warranties of the Company.................................................2
(a) Organization, Good Standing and Power.............................................................2
(b) Authorization; Enforcement........................................................................3
(c) Capitalization....................................................................................3
(d) Issuance of Securities............................................................................4
(e) No Conflicts......................................................................................4
(f) Commission Documents, Financial Statements........................................................4
(g) Subsidiaries......................................................................................5
(h) No Material Adverse Change........................................................................5
(i) No Undisclosed Liabilities........................................................................5
(j) No Undisclosed Events or Circumstances............................................................6
(k) Title to Assets...................................................................................6
(l) Actions Pending...................................................................................6
(m) Compliance with Law...............................................................................6
(n) Taxes ..........................................................................................6
(o) Certain Fees......................................................................................7
(p) Operation of Business.............................................................................7
(q) Material Agreements...............................................................................7
(r) Securities Act of 1933............................................................................7
(s) Governmental Approvals............................................................................8
(t) Employees.........................................................................................8
(u) Use of Proceeds...................................................................................8
(v) Public Utility Holding Company Act and Investment Company Act Status..............................8
(w) ERISA ............................................................................................8
(x) No Integrated Offering............................................................................9
(y) Eligibility.......................................................................................9
Section 2.2 Representations and Warranties of the Purchaser..............................................9
(a) Organization and Standing of the Purchaser........................................................9
(b) Authorization and Power...........................................................................9
(c) No Conflicts.....................................................................................10
i
(d) Acquisition for Investment.......................................................................10
(e) Accredited Purchaser.............................................................................10
(f) Rule 144.........................................................................................11
(g) Information......................................................................................11
(h) No Solicitation..................................................................................11
(i) No Endorsement...................................................................................11
(j) General .........................................................................................11
(k) No Commissions or Similar Fees...................................................................12
ARTICLE III COVENANTS............................................................................................12
Section 3.1 Securities Compliance.......................................................................12
Section 3.2 Compliance with Laws........................................................................12
Section 3.3 Keeping of Records and Books of Account.....................................................12
Section 3.4 Amendments..................................................................................13
Section 3.5 Other Agreements............................................................................13
Section 3.6 Reservation of Shares.......................................................................13
Section 3.7 Transfer Agent Instructions.................................................................13
ARTICLE IV CONDITIONS TO CLOSING.................................................................................14
Section 4.1 Conditions Precedent to the Obligation of the Company to Sell the Securities................14
Section 4.2 Conditions Precedent to the Obligation of the Purchaser to Purchase the
Shares at the Closing.......................................................................14
ARTICLE V STOCK CERTIFICATE LEGEND...............................................................................16
Section 5.1 Legend......................................................................................16
ARTICLE VI IDEMNIFICATION........................................................................................17
Section 6.1 General Indemnity...........................................................................17
Section 6.2 Indemnification Procedure...................................................................17
ARTICLE VII MISCELLANEOUS........................................................................................19
Section 7.1 Fees, Costs and Expenses....................................................................19
Section 7.2 Consent to Jurisdiction.....................................................................19
Section 7.3 Entire Agreement; Amendment.................................................................19
Section 7.4 Notices.....................................................................................19
Section 7.5 Waivers.....................................................................................20
Section 7.6 Headings....................................................................................20
Section 7.7 Successors and Assigns......................................................................20
Section 7.8 No Third Party Beneficiaries................................................................21
Section 7.9 Governing Law...............................................................................21
ii
Section 7.10 Counterparts...............................................................................21
Section 7.11 Severability...............................................................................21
Section 7.12 Further Assurances.........................................................................21
Section 7.13 Publicity..................................................................................21
iii
SCHEDULES OF THE COMPANY
------------------------
Schedule 2.1(c) Capitalization
Schedule 2.1(e) No Conflicts
Schedule 2.1(g) Subsidiaries
Schedule 2.1(h) No Material Adverse Effect
Schedule 2.1(i) No Undisclosed Liabilities
Schedule 2.1(k) Title to Assets
Schedule 2.1(l) Actions Pending
Schedule 2.1(m) Compliance with Law
Schedule 2.1(n) Taxes
Schedule 2.1(o) Certain Fees
Schedule 2.1(p) Operation of Business
Schedule 2.1(q) Material Agreements
Schedule 2.1(s) Governmental Approvals
Schedule 2.1(t) Employees
SCHEDULES OF THE PURCHASERS
---------------------------
Schedule 2.2(l) No Commissions or Similar Fees
EXHIBITS
--------
Exhibit A Form of Warrant
Exhibit B Form of Registration Rights Agreement
Exhibit C Form of Irrevocable Transfer Agent Instructions
Exhibit D Form of Legal Opinion
iv
COMMON STOCK AND WARRANT PURCHASE AGREEMENT
This COMMON STOCK AND WARRANT PURCHASE AGREEMENT dated as of May 4,
2001 (this "Agreement"), by and between XYBERNAUT CORPORATION, INC., a Delaware
corporation (the "Company"), and ALPHA CAPITAL AKTIENGESELLSCHAFT (the
"Purchaser").
RECITALS
WHEREAS, upon the terms and subject to the conditions contained herein,
the Company desires to issue and sell to the Purchaser, and the Purchaser
desires to purchase from the Company 952,381 shares of the Company's common
stock, par value $.01 per share (the "Common Stock"), and warrants to purchase
285,714 shares of Common Stock, in the form attached hereto as Exhibit A (the
"Warrants").
WHEREAS, such investments will be made in reliance upon the provisions
of Section 4(2) of the Securities Act of 1933, as amended, and the rules and
regulations promulgated thereunder (the "Securities Act"), including Regulation
D ("Regulation D"), and/or upon such other exemption from the registration
requirements of the Securities Act as may be available with respect to any or
all of the investments to be made hereunder.
NOW, THEREFORE, the parties hereto agree as follows:
ARTICLE I
PURCHASE AND SALE OF THE SHARES AND THE WARRANTS
Section 1.1 Purchase and Sale of the Shares. Upon the following terms
and subject to the conditions contained herein, the Company shall issue and sell
to the Purchaser and the Purchaser shall purchase from the Company the 952,381
shares of Common Stock (the "Shares"). Upon the following terms and subject to
the conditions contained herein, the Purchaser shall be issued Warrants. The
purchase price per share of Common Stock shall be $2.10.
Section 1.2 The Securities. The Company has authorized and has reserved
and covenants to continue to reserve, free of preemptive rights and other
similar contractual rights of stockholders, a sufficient number of its
authorized but unissued shares of its Common Stock to effect the issuance of the
Shares and exercise of the Warrants. Any shares of Common Stock issuable upon
exercise of the Warrants (and such shares when issued) are herein referred to as
(the "Warrant Shares"). The Shares, the Warrants and the Warrant Shares are
sometimes collectively referred to herein as the "Securities".
Section 1.3 Purchase Price and Closing. In consideration of and in
express reliance upon the representations, warranties, covenants, terms and
conditions of this Agreement, the Company agrees to issue and sell to the
Purchaser and the Purchaser, agrees to purchase the Shares for an aggregate
purchase price of $2,000,000. The closing under this Agreement shall take place
at the offices of Jenkens & Xxxxxxxxx Xxxxxx Xxxxxx LLP, The Chrysler Building,
000 Xxxxxxxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000 (the "Closing") at 10:00 a.m.
E.S.T. on (i) the date on which the last to be fulfilled or waived of the
conditions set forth in Article IV hereof and applicable to the Closing shall be
fulfilled or waived in accordance herewith or (ii) such other time and place or
on such date as the Purchaser and the Company may agree upon (the "Closing
Date").
Section 1.4 Warrant. Concurrently with the issuance of the Shares, the
Company shall issue to the Purchaser Warrants to purchase 285,714 shares of
Common Stock. The Warrants shall have an exercise price equal to the Exercise
Price (as defined in the Warrant) and shall expire on the fourth (4th)
anniversary of the issuance date of such Warrants.
ARTICLE II
REPRESENTATIONS AND WARRANTIES
Section 2.1 Representation and Warranties of the Company. The Company
hereby makes the following representations and warranties to the Purchaser,
except as set forth in the Company's disclosure schedules delivered with this
Agreement:
(a) Organization, Good Standing and Power. The Company is a corporation
duly incorporated, validly existing and in good standing under the laws of the
State of Delaware and has the requisite corporate power to own, lease and
operate its properties and assets and to conduct its business as it is now being
conducted and to enter into this Agreement and to perform its obligations
hereunder. The Company does not have any subsidiaries or own securities of any
kind in any other entity, except as set forth in the Company's Annual Report on
Form 10-K for the fiscal year ended December 31, 2000 (the "Form 10-K); and (ii)
all of the Company's filings with the Securities and Exchange Commission (the
"SEC") prior to the date hereof (collectively, the "Commission Documents") or in
Schedule 2.1(g) hereto. The Company and each subsidiary is duly qualified as a
foreign corporation to do business and is in good standing in every jurisdiction
in which the nature of the business conducted or property owned by it makes such
qualification necessary except for any jurisdiction(s) (alone or in the
aggregate) in which the failure to be so qualified will not have a Material
Adverse Effect (as defined hereinafter) on the Company's financial condition.
For the purposes of this Agreement, "Material Adverse Effect" means any adverse
effect on the business, operations, properties, prospects, assets or financial
condition of the Company or its subsidiaries and which is material to such
entity or other entities controlling or controlled by such entity or which is
likely to materially hinder the performance by the Company of its obligation
hereunder and under the other Transaction Documents (as defined in Section
2.1(b) hereof).
2
(b) Authorization; Enforcement. The Company has the requisite corporate
power and authority to enter into and perform its obligations under this
Agreement, the Registration Rights Agreement attached as Exhibit B hereto (the
"Registration Rights Agreement"), the Transfer Agent Instructions (as defined in
Section 3.7 hereof) and the Warrants (collectively, the "Transaction Documents")
and to issue and sell the Shares in accordance with the terms hereof and the
Warrants. The execution, delivery and performance of each of the Transaction
Documents by the Company and the consummation by the Company of the transactions
contemplated hereby and thereby have been duly and validly authorized by all
necessary corporate action, and no further consent or authorization of the
Company or the Company's board of directors or its stockholders is required.
This Agreement has been duly executed and delivered by the Company. The
Registration Rights Agreement will have been duly executed and delivered by the
Company on or before the Closing Date. Each of the Transaction Documents
constitutes, or shall constitute when executed and delivered, a valid and
binding obligation of the Company enforceable against the Company in accordance
with its terms, except as such enforceability may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium, liquidation,
conservatorship, receivership or similar laws relating to, or affecting
generally the enforcement of, creditor's rights and remedies or by other
equitable principles of general application.
(c) Capitalization. The authorized capital stock of the Company and the
shares thereof issued and outstanding as of the date hereof are set forth on
Schedule 2.1(c) hereto. All of the outstanding shares of the Company's Common
Stock have been duly and validly authorized. Except as set forth in this
Agreement and the Registration Rights Agreement and as set forth in the
Commission Documents or on Schedule 2.1(c) hereto, no shares of Common Stock or
any other securities issued by the Company are entitled to preemptive rights and
there are no outstanding options, warrants, scrip, rights to subscribe to, call
or commitments of any character whatsoever relating to, or securities or rights
convertible into, any shares of capital stock of the Company. Furthermore,
except as set forth in this Agreement and the Registration Rights Agreement and
as set forth in the Commission Documents or on Schedule 2.1(c), there are no
contracts, commitments, understandings, or arrangements by which the Company is
or may become bound to issue additional shares of the capital stock of the
Company or options, securities or rights convertible into shares of capital
stock of the Company. Except for customary transfer restrictions contained in
agreements entered into by the Company in order to sell restricted securities or
as provided on the Commission Documents or Schedule 2.1 (c) hereto, the Company
is not a party to or bound by any agreement or understanding granting
anti-dilution rights to any person with respect to any of its equity or debt
securities. The Company is not a party to, and it has no knowledge of, any
agreement or understanding restricting the voting or transfer of any shares of
the capital stock of the Company. Except as set forth on the Commission
Documents or Schedule 2.1(c) hereto, the offer and sale of all capital stock,
convertible securities, rights, warrants, or options of the Company issued prior
to the Closing complied with all applicable federal and state securities laws,
and no holder of such securities has a right of rescission or claim for damages
with respect thereto which could have a Material Adverse Effect. The Company has
furnished or made available to the Purchaser true and correct copies of the
Company's Articles of Incorporation as in effect on the date hereof (the
"Articles"), and the Company's Bylaws as in effect on the date hereof (the
"Bylaws").
3
(d) Issuance of Securities. The Shares to be issued at the Closing have
been duly authorized by all necessary corporate action and, when paid for or
issued in accordance with the terms hereof, the Shares shall be validly issued
and outstanding, fully paid and nonassessable, and free from preemptive rights,
taxes upon issuance, liens and similar charges caused by the Company and
entitled to all applicable rights and preferences set forth in the Articles.
When the Warrant Shares are issued in accordance with the terms of this
Agreement and as set forth in the Warrants, such shares will be duly authorized
by all necessary corporate action and validly issued and outstanding, fully paid
and non-assessable, and free from preemptive rights, taxes upon issuance, liens
and other similar charges caused by the Company, and the holders shall be
entitled to all rights accorded to a holder of Common Stock.
(e) No Conflicts. Except as set forth in the Commission Documents or
Schedule 2.1(e) attached hereto, the execution, delivery and performance of the
Transaction Documents by the Company and the consummation by the Company of the
transactions contemplated herein and therein do not and will not (i) violate any
provision of the Company's Articles or Bylaws, (ii) conflict with, or constitute
a default (or an event which with notice or lapse of time or both would become a
default) under, or give to others any rights of termination, amendment,
acceleration or cancellation of, any agreement, mortgage, deed of trust,
indenture, note, bond, license, lease agreement, instrument or obligation to
which the Company is a party or by which any of its respective properties or
assets are bound, (iii) create or impose a lien, mortgage, security interest,
charge or encumbrance of any nature whatsoever on any property of the Company
under any agreement or any commitment to which the Company is a party or by
which the Company is bound or by which any of its respective properties or
assets are bound, or (iv) result in a violation of any federal, state, local or
foreign statute, rule, regulation, order, judgment or decree (including federal
and state securities laws and regulations) applicable to the Company or any of
its subsidiaries or by which any property or asset of the Company or any of its
subsidiaries are bound or affected, except, in all cases other than violations
pursuant to clause (i) above, for such conflicts, defaults, terminations,
amendments, acceleration, cancellations and violations as would not,
individually or in the aggregate, have a Material Adverse Effect. The business
of the Company and its subsidiaries is not being conducted in violation of any
laws, ordinances or regulations of any governmental entity, except for possible
violations which singularly or in the aggregate do not and will not have a
Material Adverse Effect. The Company is not required under federal, state or
local law, rule or regulation to obtain any consent, authorization or order of,
or make any filing or registration with, any court or governmental agency in
order for it to execute, deliver or perform any of its obligations under the
Transaction Documents, or issue and sell the Shares and the Warrant Shares in
accordance with the terms hereof or thereof (other than any filings which may be
required to be made by the Company with the Commission or state securities
administrators subsequent to a Closing, and any registration statement which may
be filed pursuant hereto); provided that, for purposes of the representation
made in this sentence, the Company is assuming and relying upon the accuracy of
the relevant representations and agreements of the Purchaser herein.
(f) Commission Documents, Financial Statements. The Company has
provided to the Purchaser prior to the date hereof copies of its annual report
on Form 10-KSB for
4
the fiscal year ended December 31, 2000. The Company has not provided to the
Purchaser any material non-public information or other information which,
according to applicable law, rule or regulation, should have been disclosed
publicly by the Company but which has not been so disclosed, other than with
respect to the transactions contemplated by this Agreement. The financial
statements of the Company furnished to the Purchaser comply as to form in all
material respects with applicable accounting requirements and the published
rules and regulations of the Commission or other applicable rules and
regulations with respect thereto. Such financial statements have been prepared
in accordance with generally accepted accounting principles ("GAAP") applied on
a consistent basis during the periods involved (except (i) as may be otherwise
indicated in such financial statements or the notes thereto or (ii) in the case
of unaudited interim statements, to the extent they may not include footnotes or
may be condensed or summary statements), and fairly present in all material
respects the financial position of the Company and its subsidiaries as of the
dates thereof and the results of operations and cash flows for the periods then
ended (subject, in the case of unaudited statements, to normal year-end audit
adjustments).
(g) Subsidiaries. The Commission Documents or Schedule 2.1(g) hereto
sets forth each subsidiary of the Company showing the jurisdiction of its
incorporation or organization and showing the percentage of the Company's
ownership of the outstanding stock or other interests of such subsidiary. For
the purposes of this Agreement, "subsidiary" shall mean any corporation or other
entity of which at least a majority of the securities or other ownership
interest having ordinary voting power (absolutely or contingently) for the
election of directors or other persons performing similar functions are at the
time owned directly or indirectly by the Company and/or any of its other
subsidiaries. All of the outstanding shares of capital stock of each subsidiary
have been duly authorized and validly issued, and are fully paid and
non-assessable. Except as disclosed on Schedule 2.1(g) there are no outstanding
preemptive, conversion or other rights, options, warrants or agreements granted
or issued by or binding upon any subsidiary for the purchase or acquisition of
any shares of capital stock of any subsidiary or any other securities
convertible into, exchangeable for or evidencing the rights to subscribe for any
shares of such capital stock. Neither the Company nor any subsidiary is subject
to any obligation (contingent or otherwise) to repurchase or otherwise acquire
or retire any shares of the capital stock of any subsidiary or any convertible
securities, rights, warrants or options of the type described in the preceding
sentence. Neither the Company nor any subsidiary is party to, nor has any
knowledge of, any agreement restricting the voting or transfer of any shares of
the capital stock of any subsidiary.
(h) No Material Adverse Change. Since December 31, 2000, the date
through which the most recent report of the Company has been prepared and filed
with the Commission (a copy of which is included in the Commission Documents)
the Company has not experienced or suffered any Material Adverse Effect, except
as disclosed on Schedule 2.1(h) hereto.
(i) No Undisclosed Liabilities. Except as disclosed in the Commission
Documents or on Schedule 2.1(i) hereto, neither the Company nor any of its
subsidiaries has any liabilities, obligations, claims or losses (whether
liquidated or unliquidated, secured or unsecured, absolute, accrued, contingent
or otherwise) other than those incurred in the ordinary
5
course of the Company's or its subsidiaries respective businesses since December
31, 2000, and which, individually or in the aggregate, do not or would not have
a Material Adverse Effect.
(j) No Undisclosed Events or Circumstances. No event or circumstance
has occurred or exists with respect to the Company or its subsidiaries or their
respective businesses, properties, prospects, operations or financial condition,
which, under applicable law, rule or regulation, requires public disclosure or
announcement by the Company but which has not been so publicly announced or
disclosed.
(k) Title to Assets. Each of the Company and its subsidiaries has good
and marketable title to all of its real and personal property, free of any
mortgages, pledges, charges, liens, security interests or other encumbrances,
except for those indicated in the Commission Documents or on Schedule 2.1(k)
hereto or such that, individually or in the aggregate, do not cause a Material
Adverse Effect on the Company's financial condition or operating results. Except
as described in the Commission Documents or on Schedule 2.1(k) hereto, all said
leases of the Company and each of its subsidiaries are valid and subsisting and
in full force and effect.
(l) Actions Pending. There is no action, suit, claim, investigation or
proceeding pending or, to the knowledge of the Company, threatened against the
Company or any subsidiary which questions the validity of this Agreement or the
transactions contemplated hereby or any action taken or to be taken pursuant
hereto or thereto. To the knowledge of the Company, there is no action, suit,
claim, investigation or proceeding pending or threatened, against or involving
the Company, any subsidiary or any of their respective properties or assets,
except as set forth in the Commission Documents or Schedule 2.1(l) hereto. There
are no outstanding orders, judgments, injunctions, awards or decrees of any
court, arbitrator or governmental or regulatory body against the Company or any
subsidiary or any officers or directors of the Company or subsidiary in their
capacities as such.
(m) Compliance with Law. The business of the Company and the
subsidiaries has been and is presently being conducted in accordance with all
applicable federal, state and local governmental laws, rules, regulations and
ordinances, except as set forth in the Commission Documents or Schedule 2.1(m)
hereto or such that, individually or in the aggregate, the noncompliance
therewith would not have a Material Adverse Effect. The Company and each of its
subsidiaries have all franchises, permits, licenses, consents and other
governmental or regulatory authorizations and approvals necessary for the
conduct of its business as now being conducted by it unless the failure to
possess such franchises, permits, licenses, consents and other governmental or
regulatory authorizations and approvals, individually or in the aggregate, could
not reasonably be expected to have a Material Adverse Effect.
(n) Taxes. Except as set forth in the Commission Documents or Schedule
2.1(n) hereto, the Company and each of the subsidiaries has accurately prepared
and filed all federal, state and other tax returns required by law to be filed
by it, has paid or made provisions for the payment of all taxes shown to be due
and all additional assessments, and adequate provisions have been and are
reflected in the financial statements of the Company and the subsidiaries for
all current taxes and other charges to which the Company or any subsidiary is
6
subject and which are not currently due and payable. Except as disclosed on
Schedule 2.1(n) hereto, none of the federal income tax returns of the Company or
any subsidiary have been audited by the Internal Revenue Service. The Company
has no knowledge of any additional assessments, adjustments or contingent tax
liability (whether federal or state) of any nature whatsoever, whether pending
or threatened against the Company or any subsidiary for any period, nor of any
basis for any such assessment, adjustment or contingency.
(o) Certain Fees. The Company has not employed any broker or finder or
incurred any liability for any brokerage or investment banking fees,
commissions, finders' or structuring fees, financial advisory fees or other
similar fees in connection with the Transaction Documents, except as set forth
on Schedule 2.1(o) hereto which fees shall be paid by the Company. All those
entities listed on Schedule 2.1(o) hereto are broker/dealers (i) registered and
in good standing with the National Association of Securities Dealers, Inc. and
(ii) registered pursuant to Section 15 of the Securities Exchange Act of 1934,
as amended (the "Exchange Act").
(p) Operation of Business. The Company and each of the subsidiaries
owns or possesses all patents, trademarks, domain names (whether or not
registered) and any patentable improvements or copyrightable derivative works
thereof, websites and intellectual property rights relating thereto, service
marks, trade names, copyrights, licenses and authorizations and all rights with
respect to the foregoing, which are necessary for the conduct of its business as
now conducted without any conflict with the rights of others except as disclosed
in the Commission Documents or on Schedule 2.1(p).
(q) Material Agreements. Except as set forth in the Commission
Documents or on Schedule 2.1(q) hereto, or as previously disclosed by the
Company to Purchaser, neither the Company nor any subsidiary is a party to any
written or oral contract, instrument, agreement, commitment, obligation, plan or
arrangement, a copy of which would be required to be filed with the Commission
as an exhibit to a registration statement on Form S-3 or applicable form
(collectively, "Material Agreements") if the Company or any subsidiary were
registering securities under the Securities Act. Except as set forth in the
Commission Documents or on Schedule 2.1(q) hereto, the Company and each of its
subsidiaries has in all material respects performed all the obligations required
to be performed by them to date under the foregoing agreements, have received no
notice of default and, to the best of the Company's knowledge are not in default
under any Material Agreement now in effect, the result of which could cause a
Material Adverse Effect. No written or oral contract, instrument, agreement,
commitment, obligation, plan or arrangement of the Company or of any subsidiary
limits or shall limit the payment of dividends on the Company's Common Stock.
(r) Securities Act of 1933. The Company has complied and will comply
with all applicable federal and state securities laws in connection with the
offer, issuance and sale of the Shares and the Warrants hereunder. Neither the
Company nor anyone acting on its behalf, directly or indirectly, has or will
sell, offer to sell or solicit offers to buy any of the Shares, or similar
securities to, or solicit offers with respect thereto from, or enter into any
preliminary conversations or negotiations relating thereto with, any person, or
has taken or will take any
7
action so as to bring the issuance and sale of any of the Shares under the
registration provisions of the Securities Act and any other applicable federal
and state securities laws. Assuming the representations set forth in Section 2.2
hereof are true, the Securities may be issued without registration under the
Securities Act of 1933. Neither the Company nor any of its affiliates, nor any
person acting on its or their behalf, has engaged in any form of general
solicitation or general advertising (within the meaning of Regulation D under
the Securities Act) in connection with any of the Shares.
(s) Governmental Approvals. Except as set forth in the Commission
Documents or on Schedule 2.1(s) hereto, and except for the filing of any notice
prior or subsequent to the Closing that may be required under applicable state
or federal securities laws (which if required, shall be filed on a timely
basis), including, but not limited to, the filing of a registration statement or
statements pursuant to the Registration Rights Agreement, no authorization,
consent, approval, license exemption of, filing or registration with any court
or governmental department, commission, board, bureau, agency or
instrumentality, domestic or foreign, is or will be necessary for, or in
connection with, the execution or delivery of the Shares, or for the performance
by the Company of its obligations under the Transaction Documents.
(t) Employees. Neither the Company nor any subsidiary has any
collective bargaining arrangements or agreements covering any of its employees,
except as set forth in the Commission Documents or on Schedule 2.1(t) hereto.
Except as set forth in the Commission Documents or on Schedule 2.1(t) hereto,
neither the Company nor any subsidiary has any employment contract, agreement
regarding proprietary information, non-competition agreement, non-solicitation
agreement, confidentiality agreement, or any other similar contract or
restrictive covenant, relating to the right of any officer, employee or
consultant to be employed or engaged by the Company or such subsidiary. Since
December 31, 2000, no officer, consultant or key employee of the Company or any
subsidiary whose termination, either individually or in the aggregate, could
have a Material Adverse Effect, has terminated or, to the knowledge of the
Company, has any present intention of terminating his or her employment or
engagement with the Company or any subsidiary.
(u) Use of Proceeds. The proceeds from the sale of the Shares and the
Warrants will be used by the Company for working capital and general corporate
purposes.
(v) Public Utility Holding Company Act and Investment Company Act
Status. The Company is not a "holding company" or a "public utility company" as
such terms are defined in the Public Utility Holding Company Act of 1935, as
amended. The Company is not, and as a result of and immediately upon any Closing
will not be, an "investment company" or a company "controlled" by an "investment
company," within the meaning of the Investment Company Act of 1940, as amended.
(w) ERISA. No liability to the Pension Benefit Guaranty Corporation has
been incurred with respect to any Plan by the Company or any of its subsidiaries
which is or would be materially adverse to the Company and its subsidiaries. The
execution, delivery and performance of this Agreement and the other Transaction
Documents and the issue and sale of
8
the Shares and the Warrants will not involve any transaction which is subject to
the prohibitions of Section 406 of ERISA or in connection with which a tax could
be imposed pursuant to Section 4975 of the Internal Revenue Code of 1986, as
amended, provided that, if the Purchaser, or any person or entity that owns a
beneficial interest in the Purchaser, is an "employee pension benefit plan"
(within the meaning of Section 3(2) of ERISA) with respect to which the Company
is a "party in interest" (within the meaning of Section 3(14) of ERISA), the
requirements of Sections 407(d)(5) and 408(e) of ERISA, if applicable, are met.
As used in this Section 2.1(z), the term "Plan" shall mean an "employee pension
benefit plan" (as defined in Section 3 of ERISA) which is or has been
established or maintained, or to which contributions are or have been made, by
the Company or any subsidiary or by any trade or business, whether or not
incorporated, which, together with the Company or any subsidiary, is under
common control, as described in Section 414(b) or (c) of the Code.
(x) No Integrated Offering. To the best of the Company's knowledge,
neither the Company, nor any of its affiliates, nor any person acting on its or
their behalf has, directly or indirectly, made any offers or sales of any
security or solicited any offers to buy any security, under circumstances that
would require registration of any of the Securities under the 1933 Act or cause
this offering of the Securities to be integrated with prior offerings by the
Company for purposes of the 1933 Act or any applicable stockholder approval
provisions, including, without limitation, under the rules and regulations of
any exchange or automated quotation system on which any of the Securities of the
Company are listed or designated, nor will the Company or any of its
subsidiaries take any actions or steps that would require registration of any of
the Securities under the 1933 Act or cause the offering of the Securities to be
integrated with other offerings.
(y) Eligibility. The Company is currently eligible to register the
resale of the Securities on a registration statement on Form S-3 under the 1933
Act.
Section 2.2 Representations and Warranties of the Purchaser. The
Purchaser hereby makes the following representations and warranties to the
Company:
(a) Organization and Standing of the Purchaser. The Purchaser is a
corporation, limited liability company or partnership duly incorporated or
organized, validly existing and in good standing under the laws of the
jurisdiction of its incorporation or organization, and the Purchaser was not
formed for the specific purpose of acquiring the Securities.
(b) Authorization and Power. The Purchaser has the requisite power and
authority to enter into and perform this Agreement and the Registration Rights
Agreement and to purchase the Shares and the Warrants being sold to it
hereunder. The execution, delivery and performance of this Agreement and the
Registration Rights Agreement and the documents contemplated hereby by the
Purchaser and the consummation by it of the transactions contemplated hereby and
thereby have been duly authorized by all necessary corporate action and no
further consent or authorization of the Purchaser or its board of directors,
stockholders, members, managers or partners, as the case may be, is required.
Each of this Agreement and the Registration Rights Agreement will have been duly
executed and delivered by the Purchaser on the closing Date. Each of this
Agreement and the
9
Registration Rights Agreement constitutes, or shall constitute when executed and
delivered, a valid and binding obligation of the Purchaser enforceable against
the Purchaser in accordance with its terms, except as such enforceability may be
limited by applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation, conservatorship, receivership, or similar laws relating to, or
affecting generally the enforcement of, creditor's rights and remedies or by
other equitable principles of general application.
(c) No Conflicts. The execution, delivery and performance of this
Agreement and the Registration Rights Agreement and the documents contemplated
hereby and thereby and the consummation by the Purchaser of the transactions
contemplated hereby or thereby or relating hereto or thereto do not and will not
(i) result in a violation of the Purchaser's charter documents, by-laws,
partnership agreement, operating agreement or other organizational documents, or
(ii) conflict with, constitute a default (or an event which with notice or lapse
of time or both would become a default) under, or give to others any rights of
termination, amendment, acceleration or cancellation of any agreement, indenture
or instrument to which the Purchaser is a party, or result in a violation of any
law, rule, or regulation, or any order, judgment or decree of any court or
governmental agency applicable to the Purchaser or its properties, except for
such conflicts, defaults and violations as would not, individually or in the
aggregate, prohibit or otherwise interfere with the ability of the Purchaser to
enter into and perform its obligations under this Agreement in any material
respect. The Purchaser is not required to obtain any consent, authorization or
order of, or make any filing or registration with, any court or governmental
agency in order for it to execute, deliver or perform any of its obligations
under this Agreement, the Registration Rights Agreement or the documents
contemplated hereby and thereby or to purchase the Shares or the Warrants in
accordance with the terms hereof; provided that for purposes of the
representation made in this sentence, the Purchaser is assuming and relying upon
the accuracy of the relevant representations and agreements of the Company
herein.
(d) Acquisition for Investment. The Purchaser is purchasing the Shares
and the Warrants and will be acquiring the Warrant Shares solely for its own
account, for investment only and not with a view towards the public sale or
distribution thereof. The Purchaser agrees not to sell, assign or otherwise
transfer any of its Securities except in accordance with federal and state
securities laws applicable to such disposition. The Purchaser acknowledges that
it is able to bear the financial risks associated with an investment in the
Securities and that it has been given full access to such records of the Company
and its subsidiaries and to the officers of the Company and its subsidiaries as
it has deemed necessary or appropriate to conduct its due diligence
investigation. The Purchaser is capable of evaluating the risks and merits of an
investment in the Securities by virtue of its experience as an investor and its
knowledge, experience and sophistication in financial and business matters and
the Purchaser is capable of bearing the entire loss of its investment in the
Securities.
(e) Accredited Purchaser. The Purchaser is an "accredited investor" as
defined in Regulation D promulgated under the Securities Act and is incorporated
in the state of Illinois.
10
(f) Rule 144. The Purchaser understands that the Securities must be
held indefinitely unless such Securities are registered under the Securities Act
or an exemption from registration is available. The Purchaser acknowledges that
the Purchaser is familiar with Rule 144 of the rules and regulations promulgated
pursuant to the Securities Act ("Rule 144"), and that the Purchaser has been
advised that Rule 144 permits resales only under certain circumstances. The
Purchaser understands that to the extent that Rule 144 is not available, it will
be unable to sell any Securities without either registration under the
Securities Act or the existence of another exemption from such registration
requirement.
(g) Information. The Purchaser and its advisors, if any, have been
furnished with all materials relating to the business, finances and operations
of the Company and materials relating to the offer and sale of the Securities
which have been requested by the Purchaser. The Purchaser and its advisors, if
any, have been afforded the opportunity to ask questions of and receive answers
from, or obtain additional information from, the executive officers of the
Company the financial and other affairs of the Company. The Purchaser has sought
such accounting, legal and tax advice as it has considered necessary to make an
informed investment decision with respect to its acquisition of the Securities.
The Purchaser understands that it (and not the Company) shall be responsible for
its own tax liabilities that may arise as a result of this investment or the
transactions contemplated by this Agreement. Without limiting the generality of
the foregoing, the Purchaser has also had the opportunity to obtain and to
review the Commission Documents.
(h) No Solicitation. The Purchaser acknowledges that the Shares and the
Warrants were not offered to the Purchaser by means of any form of general or
public solicitation or general advertising, or publicly disseminated
advertisements or sales literature, including (i) any advertisement, articles,
notice or other communication published in any newspaper, magazine, or similar
media, or broadcast over television or radio, or (ii) any seminar or meeting to
which the purchaser was invited by any of the foregoing means of communications.
(i) No Endorsement. The Purchaser understands that no United States
federal or state agency or any other government or governmental agency
(including, without limitation, the SEC) has passed on or made any
recommendation or endorsement of the Securities.
(j) General. The Purchaser understands that the Shares and the Warrants
are being offered and sold, and the Warrant Shares are being offered, to the
Purchaser in reliance on specific exemptions from the registration requirement
of federal and state securities laws and that the Company is relying upon the
truth and accuracy of, and the compliance with, the representations, warranties,
agreements, acknowledgments and understanding of the Purchaser set forth herein
in order to determine the applicability of such exemptions and the eligibility
of the Purchaser to acquire the Shares and the Warrants and to receive an offer
of the Warrant Shares.
11
(k) No Commissions or Similar Fees. In connection with the purchase of
the Shares and Warrants by the Purchaser, the Purchaser has not and will not
pay, and has no knowledge of the payment of, any commission or other direct or
indirect remuneration to any person or entity for soliciting or otherwise
coordinating the purchase of such securities, except as set forth on Schedule
2.2(k) hereto. All such persons or entities listed on Schedule 2.2(k) hereto are
duly licensed and/or registered to engage in securities offering and selling
activities (or are exempt from such licensing and/or registration requirements)
under applicable federal laws and the laws of the state(s) in which such
activities have taken place in connection with the transaction contemplated by
this agreement.
ARTICLE III
COVENANTS
The Company covenants with the Purchaser, for so long as the Shares
and/or the Warrants remain outstanding, as follows (which covenants are for the
benefit of the Purchaser and its permitted assignees):
Section 3.1 Securities Compliance.
(a) The Company shall notify the Commission in accordance with their
rules and regulations of the transactions contemplated by any of the Transaction
Documents, as may be required, and shall take all other necessary action and
proceedings as may be required and permitted by applicable law, rule and
regulation, for the legal and valid issuance of the Shares and the Warrant
Shares to the Purchaser or subsequent holders and will take no action to cause
integration under the 1933 Securities Act or the rules of Nasdaq.
(b) The Company is relying upon the truth and accuracy of the
representations, warranties, agreements, acknowledgments and understandings of
the Purchaser set forth herein in order to determine the applicability of
federal and state securities laws exemptions and the suitability of the
Purchaser to acquire the Shares and the Warrants.
Section 3.2 Compliance with Laws. The Company shall comply, and cause
each subsidiary to comply, with all applicable laws, rules, regulations and
orders, noncompliance with which could have a Material Adverse Effect.
Section 3.3 Keeping of Records and Books of Account. The Company shall
keep and cause each subsidiary to keep adequate records and books of account, in
which entries will be made in accordance with United States generally accepted
accounting principles consistently applied, reflecting all material financial
transactions of the Company and its subsidiaries, and in which, for each fiscal
year, all proper reserves for depreciation, depletion, obsolescence,
amortization, taxes, bad debts and other purposes in connection with its
business shall be made.
12
Section 3.4 Amendments. The Company shall not amend or waive any
provision of the Articles or Bylaws of the Company, or the Registration Rights
Agreement in any way that would adversely affect the dividend rights, exercise
rights, voting rights or redemption rights of the holders of the Shares, the
Warrants or the Warrant Shares.
Section 3.5 Other Agreements. The Company shall not enter into any
agreement in which the terms of such agreement would restrict or impair the
right or ability to perform of the Company or any subsidiary under any
Transaction Document.
Section 3.6 Reservation of Shares. So long as any of the Warrants
remain outstanding, the Company shall take all action necessary to at all times
have authorized, and reserved for the purpose of issuance, no less than 100% of
the aggregate number of shares of Common Stock needed to provide for the
issuance of the Warrant Shares.
Section 3.7 Transfer Agent Instructions. The Company shall issue
irrevocable instructions to its transfer agent, and any subsequent transfer
agent, to issue certificates, registered in the name of the Purchaser or its
respective nominee(s), for the Shares and the Warrant Shares in such amounts as
specified from time to time by Purchaser to the Company upon issuance of the
Shares or exercise of the Warrants in the form of Exhibit C attached hereto (the
"Irrevocable Transfer Agent Instructions"). Prior to registration of the Shares
and the Warrant Shares under the Securities Act, all such certificates shall
bear the restrictive legend specified in Section 5.1 of this Agreement. The
Company warrants that no instruction other than the Irrevocable Transfer Agent
Instructions referred to in this Section 3.7 will be given by the Company to its
transfer agent and that the Shares and the Warrant Shares shall otherwise be
freely transferable on the books and records of the Company as and to the extent
provided in this Agreement and the Registration Rights Agreement. Nothing in
this Section 3.7 shall affect in any way the Purchaser's obligations and
agreements set forth in Section 5.1 to comply with all applicable prospectus
delivery requirements, if any, upon resale of the Shares or the Warrant Shares.
If a Purchaser provides the Company with an opinion of counsel, in a generally
acceptable form, to the effect that a public sale, assignment or transfer of the
Shares or Warrant Shares may be made without registration under the Securities
Act or such Purchaser provides the Company with reasonable assurances that the
Shares or the Warrant Shares can be sold pursuant to Rule 144 without any
restriction as to the number of securities acquired as of a particular date that
can then be immediately sold, the Company shall permit the transfer, and, in the
case of the Shares and the Warrant Shares, promptly instruct its transfer agent
to issue one (1) or more certificates in such name and in such denominations as
specified by such Purchaser and without any restrictive legend. The Company
acknowledges that a breach by it of its obligations under this Section 3.7 will
cause irreparable harm to the Purchaser by vitiating the intent and purpose of
the transaction contemplated hereby. Accordingly, the Company acknowledges that
the remedy at law for a breach of its obligations under this Section 3.7 will be
inadequate and agrees, in the event of a breach or threatened breach by the
Company of the provisions of this Section 3.7, that the Purchaser shall be
entitled, in addition to all other available remedies, to an order and/or
injunction restraining any breach and requiring immediate issuance and transfer,
without the necessity of showing economic loss and without any bond or other
security being required.
13
ARTICLE IV
CONDITIONS TO CLOSING
Section 4.1 Conditions Precedent to the Obligation of the Company to
Sell the Securities. The obligation hereunder of the Company to issue and sell
the Shares and the Warrants to the Purchaser is subject to the satisfaction or
waiver, at or before the Closing, of each of the conditions set forth below.
These conditions are for the Company's sole benefit and may be waived by the
Company at any time in its sole discretion.
(a) Accuracy of Purchaser's Representations and Warranties. The
representations and warranties of Purchaser shall be true and correct in all
material respects as of the date when made and as of the Closing as though made
at that time, except for representations and warranties that are expressly made
as of a particular date, which shall be correct in all material respects as of
such date.
(b) Performance by the Purchaser. Purchaser shall have performed,
satisfied and complied in all material respects with all covenants, agreements
and conditions required by this Agreement to be performed, satisfied or complied
with by Purchaser at or prior to the Closing, including having paid by wire
transfer of funds to the Company in accordance with this Agreement the Purchase
Price and Purchaser shall have executed and delivered this Agreement and the
Registration Rights Agreement of the Company.
(c) No Injunction. No statute, rule, regulation, executive order,
decree, ruling or injunction shall have been enacted, entered, promulgated or
endorsed by any court or governmental authority of competent jurisdiction which
prohibits the consummation of any of the transactions contemplated by this
Agreement.
Section 4.2 Conditions Precedent to the Obligation of the Purchaser to
Purchase the Shares at the Closing. The obligation hereunder of Purchaser to
acquire and pay for the Shares and Warrants is subject to the satisfaction or
waiver, at or before the Closing, of each of the conditions set forth below.
These conditions are for Purchaser's sole benefit and may be waived by Purchaser
at any time in its sole discretion.
(a) Accuracy of the Company's Representations and Warranties. Each of
the representations and warranties of the Company shall be true and correct in
all material respects as of the date when made and as of the Closing as though
made at that time (except for representations and warranties that speak as of a
particular date), which shall be true and correct in all material respects as of
such date.
(b) Performance by the Company. The Company shall have performed,
satisfied and complied in all material respects with all covenants, agreements
and conditions required by this Agreement to be performed, satisfied or complied
with by the Company at or prior to the Closing.
14
(c) No Suspension, Etc. From the date hereof to the Closing Date,
trading in the Company's Common Stock shall not have been suspended by the
Commission, and, at any time prior to the Closing Date, trading in securities
generally as reported by Bloomberg Financial Markets ("Bloomberg") shall not
have been suspended or limited, or minimum prices shall not have been
established on securities whose trades are reported by Bloomberg, or on the New
York Stock Exchange, nor shall a banking moratorium have been declared either by
the United States, or New York State authorities, nor shall there have occurred
any material outbreak or escalation of hostilities or other national or
international calamity or crisis of such magnitude in its effect on, or any
material adverse change in any financial market which, in each case, in the
judgment of such Purchaser, makes it impracticable or inadvisable to acquire the
Shares and Warrant.
(d) No Injunction. No statute, rule, regulation, executive order,
decree, ruling or injunction shall have been enacted, entered, promulgated or
endorsed by any court or governmental authority of competent jurisdiction which
prohibits the consummation of any of the transactions contemplated by this
Agreement.
(e) No Proceedings or Litigation. No action, suit or proceeding before
any arbitrator or any governmental authority shall have been commenced, and no
investigation by any governmental authority shall have been threatened, against
the Company, or any of the officers, directors or affiliates of the Company
seeking to restrain, prevent or change the transactions contemplated by this
Agreement, or seeking damages in connection with such transactions.
(f) Opinion of Counsel, Etc. At the Closing, the Purchaser shall have
received an opinion of counsel to the Company, dated the date of such Closing,
in the form of Exhibit D hereto.
(g) Registration Rights Agreement. Prior to the Closing, the Company
shall have executed and delivered the Registration Rights Agreement to
Purchaser.
(h) Stock and Warrant Certificates. The Company shall have agreed to
deliver to the Purchaser, the certificates (in such denominations as the
Purchaser shall request) for the Shares and the Warrants being purchased by such
Purchaser as soon as practicable following the Closing.
(i) Resolutions. Prior to the Closing, the Board of Directors of the
Company shall have adopted resolutions consistent with Section 2.1(b) above in a
form reasonably acceptable to the Purchaser (the "Resolutions").
(j) Reservation of Shares. As of the Closing Date, the Company shall
have reserved out of its authorized and unissued Common Stock, solely for the
purpose of effecting the issuance of the Shares and the exercise of the
Warrants, a number of shares of Common Stock equal to at least 100% of the
shares of Common Stock which would be issuable upon issuance of the Shares and
upon exercise of the Warrants following the Closing (after giving
15
effect to the Shares and Warrants to be issued on the Closing Date and assuming
all such Shares and Warrants were fully issuable and exercisable, as applicable,
on such date regardless of any limitation on the timing or amount of such
issuances or exercises).
(k) Transfer Agent Instructions. As of the Closing Date, the
Irrevocable Transfer Agent Instructions, in the form of Exhibit C attached
hereto, shall have been delivered to the Company's transfer agent.
ARTICLE V
STOCK CERTIFICATE LEGEND
Section 5.1 Legend. Each certificate representing the Shares, the Warrants, and
the securities issued upon exercise thereof, as applicable and appropriate,
shall be stamped or otherwise imprinted with a legend in substantially the
following form (in addition to any legend required by applicable federal,
provincial or state securities or "blue sky" laws):
THE SECURITIES REPRESENTED BY THIS CERTIFICATE (THE
"SECURITIES") HAVE NOT BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") OR STATE
SECURITIES LAWS AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED,
PLEDGED OR HYPOTHECATED OR OTHERWISE DISPOSED OF UNLESS
REGISTERED UNDER THE SECURITIES ACT AND UNDER APPLICABLE
STATE SECURITIES LAWS OR XYBERNAUT CORPORATION (THE
"COMPANY") SHALL HAVE RECEIVED AN OPINION IN FORM, SCOPE AND
SUBSTANCE REASONABLY ACCEPTABLE TO THE COMPANY, OF COUNSEL,
WHO IS REASONABLY ACCEPTABLE TO THE COMPANY THAT REGISTRATION
OF SUCH SECURITIES UNDER THE SECURITIES ACT AND UNDER THE
PROVISIONS OF APPLICABLE FEDERAL AND STATE SECURITIES LAWS IS
NOT REQUIRED.
The Company agrees to reissue certificates representing the Shares,
Warrants or Warrant Shares, without the legend set forth above if at such time,
prior to making any transfer of any Shares, Warrants or Warrant Shares such
holder thereof shall give written notice to the Company describing the manner
and terms of such transfer and removal as the Company may reasonably request and
such holder otherwise complies with the terms of the Transaction Documents. The
legend set forth above shall be removed and the Company shall issue a
certificate without such legend to the holder of any Shares, Warrants or Warrant
Shares upon which it is stamped if, unless otherwise required by federal or
state securities laws, (a) the sale of such Shares, Warrants or Warrant Shares
is registered under the Securities Act (including registration pursuant to Rule
416 thereunder) as contemplated by the Registration Rights Agreement (b) such
holder provides the Company with an opinion of counsel, in form, substance and
scope customary for opinions of counsel in comparable transactions, to the
effect that a sale or transfer of such Shares, Warrants
16
or Warrant Shares may be made without registration under the Securities Act; or
(c) such holder provides the Company with reasonable assurances that such
Shares, Warrants or Warrant Shares can be sold under Rule 144(k). Purchaser
agrees that it will only sell Shares, Warrants or Warrant Shares, including
those represented by a certificate(s) from which the legend has been removed,
pursuant to an effective registration statement, under an exemption from the
registration requirements of the Securities Act or in accordance with Rule
144(k). In the event the above legend is removed from any Shares, Warrant or
Warrant Shares and the effectiveness of a registration statement covering such
Shares, Warrants or Warrant Shares is suspended or the Company determines that a
supplement or amendment thereto is required by applicable securities laws, then
upon reasonable advance notice to the Purchaser the Company may require that the
above legend be placed on any such Shares, Warrants or Warrant Shares that
cannot then be sold pursuant to an effective registration statement, under an
exemption from the registration requirements of the Securities Act or under Rule
144(k) and the Purchaser shall cooperate in the replacement of such legend. Such
legend shall thereafter be removed when such Shares, Warrants or Warrant Shares
may again be sold pursuant to an effective registration statement, under an
exemption from the registration requirements of the Securities Act or under Rule
144(k). The restrictions on transfer contained in Section 5.1 shall be in
addition to, and not by way of limitation of, any other restrictions on transfer
contained in any other section of this Agreement.
ARTICLE VI
INDEMNIFICATION
Section 6.1 General Indemnity. The Company agrees to indemnify and hold
harmless the Purchaser (and its directors, officers, affiliates, agents,
successors and assigns) from and against any and all actual losses, liabilities,
deficiencies, costs, damages and reasonable expenses (including, without
limitation, reasonable attorney's fees, charges and disbursements) incurred by
the Purchaser as a result of any breach of the covenants, representations and
warranties made by the Company herein. The Purchaser agrees, to indemnify and
hold harmless the Company and its directors, officers, affiliates, agents,
successors and assigns from and against any and all actual losses, liabilities,
deficiencies, costs, damages and reasonable expenses (including, without
limitation, reasonable attorneys' fees, charges and disbursements) incurred by
the Company as a result of any false representation or warranty or any breach of
the covenants made by Purchaser herein, provided, however, Purchaser's
indemnification obligations shall not exceed the Purchase Price.
Section 6.2 Indemnification Procedure. Any party entitled to
indemnification under this Article VI (an "indemnified party") will give written
notice to the indemnifying party of any matters giving rise to a claim for
indemnification; provided, that the failure of any party entitled to
indemnification hereunder to give notice as provided herein shall not relieve
the indemnifying party of its obligations under this Article VII, except to the
extent that the indemnifying party is actually materially prejudiced by such
failure to give notice. In case any action, proceeding or claim is brought
against an indemnified party in respect of which indemnification is sought
17
hereunder, the indemnifying party shall be entitled to participate in, unless in
the reasonable judgment of the indemnified party a conflict of interest between
it and the indemnifying party may exist with respect of such action, an action,
a proceeding or a claim, to assume the defense thereof with counsel reasonably
satisfactory to the indemnified party. In the event that the indemnifying party
advises an indemnified party that it will contest such a claim for
indemnification hereunder, or fails, within thirty (30) days of receipt of any
indemnification notice to notify, in writing, such person of its election to
defend, settle or compromise, at its sole cost and expense, any action,
proceeding or claim (or discontinues its defense at any time after it commences
such defense), then the indemnified party may, at its option, defend, settle or
otherwise compromise or pay such action or claim. In any event, unless and until
the indemnifying party elects in writing to assume and does so assume the
defense of any such claim, proceeding or action, the indemnified party's costs
and expenses arising out of the defense, settlement or compromise of any such
action, claim or proceeding shall be losses subject to indemnification
hereunder. The indemnified party shall cooperate fully with the indemnifying
party in connection with any negotiation or defense of any such action or claim
by the indemnifying party and shall furnish to the indemnifying party all
information reasonably available to the indemnified party which relates to such
action or claim. The indemnifying party shall keep the indemnified party fully
apprised at all times as to the status of the defense or any settlement
negotiations with respect thereto. If the indemnifying party elects to defend
any such action or claim, then the indemnified party shall be entitled to
participate in such defense with counsel of its choice at its sole cost and
expense, unless in the reasonable judgment of the indemnified party a conflict
of interest between it and the indemnifying party may exist with respect to such
action or claim. The indemnifying party shall not be liable for any settlement
of any action, claim or proceeding effected without its prior written consent.
Notwithstanding anything in this Article VI to the contrary, the indemnifying
party shall not, without the indemnified party's prior written consent (which
consent shall not be unreasonable withheld), settle or compromise any claim or
consent to entry of any judgment in respect thereof which imposes any future
obligation on the indemnified party or which does not include, as an
unconditional term thereof, the giving by the claimant or the plaintiff to the
indemnified party of a release from all liability in respect of such claim. The
indemnification required by this Article VI shall be made by periodic payments
of the amount thereof during the course of investigation or defense, as and when
bills are received or expense, loss, damage or liability is incurred, so long as
the indemnified party irrevocably agrees to refund such moneys if it is
ultimately determined by a court of competent jurisdiction that such party was
not entitled to indemnification. The indemnity agreements contained herein shall
be in addition to (a) any cause of action or similar rights of the indemnified
party against the indemnifying party or others and (b) any liabilities the
indemnifying party may be subject to pursuant to the law.
18
ARTICLE VII
MISCELLANEOUS
Section 7.1 Fees, Costs and Expenses. All fees, costs and expenses
incurred in connection with this Agreement and the transactions contemplated
hereby will be paid by the party incurring such fees, costs and expenses.
Section 7.2 Consent to Jurisdiction. Each of the Company and the
Purchaser (i) hereby irrevocably submits to the jurisdiction of the United
States District Court sitting in the Southern District of New York and the
courts of the State of New York located in New York county for the purposes of
any suit, action or proceeding arising out of or relating to this Agreement or
any of the other Transaction Documents or the transactions contemplated
hereunder or thereunder and (ii) hereby waives, and agrees not to assert in any
such suit, action or proceeding, any claim that it is not personally subject to
the jurisdiction of such court, that the suit, action or proceeding is brought
in an inconvenient forum or that the venue of the suit, action or proceeding is
improper. Each of the Company and Purchaser consents to process being served in
any such suit, action or proceeding by mailing a copy thereof to such party at
the address in effect for notices to it under this Agreement and agrees that
such service shall constitute good and sufficient service of process and notice
thereof. Nothing in this Section 7.2 shall affect or limit any right to serve
process in any other manner permitted by law.
Section 7.3 Entire Agreement; Amendment. This Agreement and the
exhibits attached hereto contain the entire understanding of the parties with
respect to the matters covered hereby, supersedes all prior agreements with
respect to subject matter hereof and, except as specifically set forth herein,
in the Shares or in the Warrants, neither the Company nor Purchaser makes any
representations, warranty, covenant or undertaking with respect to such matters.
No provision of this Agreement may be waived or amended other than by a written
instrument signed by the party against whom enforcement of any such amendment or
waiver is sought.
Section 7.4 Notices. Any notice, demand, request, waiver or other
communication required or permitted to be given hereunder shall be in writing
and shall be effective (a) upon hand delivery, by telex (with correct answer
back received), telecopy, facsimile or e-mail at the address or number
designated below (if delivered on a business day during normal business hours
where such notice is to be received), or the first business day following such
delivery (if delivered other than on a business day during normal business hours
where such notice is to be received) or (b) on the second business day following
the date of mailing by express courier service, fully prepaid, addressed to such
address, or upon actual receipt of such mailing, whichever shall first occur.
The addresses for such communications shall be:
19
If to the Company: Xybernaut Corporation
00000 Xxxx Xxxxx Xxxxxx
Xxxxx 000
Xxxxxxx, Xxxxxxxx 00000
Fax No.: 000-000-0000
Attention: Xxxx X. Xxxxxxxx
with copies to:
Xybernaut Corporation
00000 Xxxx Xxxxx Xxxxxx
Xxxxx 000
Xxxxxxx, Xxxxxxxx 00000
Fax No.: 000-000-0000
Attention: Xx. Xxxxxx X. Xxxxxx
and
Jenkens & Xxxxxxxxx Xxxxxx Xxxxxx LLP
The Chrysler Building
000 Xxxxxxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Fax: (000) 000-0000
Attention: Xxxxxx Xxxx Xxxxxxxx, Esq.
If to the Purchaser: At the address of such Purchaser as set
forth on the signature page to this
Agreement, with copies to Purchaser's
counsel as set forth on the signature page
or as specified in writing by such Purchaser
Any party hereto may from time to time change its address for notices
by giving at least ten (10) days written notice of such changed address to the
other party hereto.
Section 7.5 Waivers. No waiver by either party of any default with
respect to any provision, condition or requirement of this Agreement shall be
deemed to be a continuing waiver in the future or a waiver of any other
provisions, condition or requirement hereof, nor shall any delay or omission of
any party to exercise any right hereunder in any manner impair the exercise of
any such right accruing to it thereafter.
Section 7.6 Headings. The article, section and subsection headings in
this Agreement are for convenience only and shall not constitute a part of this
Agreement for any other purpose and shall not be deemed to limit or affect any
of the provisions hereof.
Section 7.7 Successors and Assigns. The Purchaser may not assign this
Agreement to any person (other than to an affiliate (as defined in Rule 144) of
the Purchaser) without the prior consent of the Company, which consent will not
be unreasonably withheld. This Agreement
20
shall be binding upon and inure to the benefit of the parties and their
successors and assigns. The parties hereto may not amend this Agreement or any
rights or obligations hereunder without the prior written consent of the Company
and the Purchaser to be affected by the amendment. After the Closing, the
assignment by a party to this Agreement of any rights hereunder shall not affect
the obligations of such party under this Agreement.
Section 7.8 No Third Party Beneficiaries. This Agreement is intended
for the benefit of the parties hereto and their respective permitted successors
and assigns and is not for the benefit of, nor may any provision hereof be
enforced by, any other person.
Section 7.9 Governing Law. This Agreement shall be governed by and
construed in accordance with the internal laws of the State of New York, without
giving effect to the choice of law provisions.
Section 7.10 Counterparts. This Agreement may be executed in any number
of counterparts, all of which taken together shall constitute one and the same
instrument and shall become effective when counterparts have been signed by each
party and delivered to the other parties hereto, it being understood that all
parties need not sign the same counterpart. In the event any signature is
delivered by facsimile transmission, the party using such means of delivery
shall cause four additional executed signature pages to be physically delivered
to the other parties within five days of the execution and delivery hereof.
Section 7.11 Severability. The provisions of this Agreement are
severable and, in the event that any court of competent jurisdiction shall
determine that any one or more of the provisions or part of the provisions
contained in this Agreement shall, for any reason, be held to be invalid,
illegal or unenforceable in any respect, such invalidity, illegality or
unenforceability shall not affect any other provision or part of a provision of
this Agreement, and this Agreement shall be reformed and construed as if such
invalid or illegal or unenforceable provision, or part of such provision, had
never been contained herein, so that such provisions would be valid, legal and
enforceable to the maximum extent possible.
Section 7.12 Further Assurances. From and after the date of this
Agreement, upon the request of Purchaser or the Company, each of the Company and
the Purchaser shall execute and deliver such instrument, documents and other
writings as may be reasonably necessary or desirable to confirm and carry out
and to effectuate fully the intent and purposes of this Agreement, the
Registration Rights Agreement and the Warrants.
Section 7.13 Publicity. The Company and the Purchaser, as the case may
be, shall not issue any press release or otherwise make any public statement or
announcement with respect to this Agreement or the transactions contemplated
hereby of which the Purchaser or the Company, respectively, shall not previously
have been advised.
21
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
duly executed by their respective authorize officer as of the date first above
written.
XYBERNAUT CORPORATION
By:
----------------------------------------
Name:
Title:
ALPHA CAPITAL AKTIENGESELLSCHAFT
By:
----------------------------------------
Name:
Title:
22
SIGNATURE PAGE TO THE
COMMON STOCK AND WARRANTS PURCHASE AGREEMENT
XYBERNAUT CORPORATION
NUMBER OF SHARES AND
PURCHASER WARRANTS TO BE PURCHASED PURCHASE PRICE NAME AND ADDRESS OF COUNSEL
--------- ------------------------ -------------- ---------------------------
Alpha Capital Aktiengesellschaft Common Shares: 952,381 $2,000,000
Pradafant 7 Warrant Shares: 285,714
Xxxxxxxxxxx - 0000
Xxxxx, Xxxxxxxxxxxxx Attn:
Attn: Xxxxxx Xxxxxxxx Tel. no.:
Fax no.:
Tel. no.:
Fax no.:
